Medifast Inc (MED)
Household and Personal Products • Consumer Staples
Financial Metrics
Price to Earnings-5.06x
Revenue Growth (1Y)-34.03%
Debt to Equity0.026x
Strengths
Valuation
Medifast Inc is overvalued
News
All
Press Releases
News
Filings

August 03, 2026Medifast Announces Second Quarter 2026 Financial Results

August 03, 202610-Q Quarterly Report for 2026 Q2

July 20, 2026Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026

July 17, 2026Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System

May 26, 2026Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer

May 04, 2026Medifast Announces First Quarter 2026 Financial Results

May 04, 202610-Q Quarterly Report for 2026 Q1

April 20, 2026Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026

March 20, 2026Medifast Announces Cooperation Agreement with Steamboat Capital

February 20, 2026Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients

February 17, 2026Medifast Announces Fourth Quarter and Full Year 2025 Financial Results

February 17, 202610-K Annual Report for 2025 FY

February 03, 2026Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

January 16, 2026People Magazine Spotlights Tiffany Howard’s Metabolic Health Journey with OPTAVIA®

January 15, 2026OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity

January 05, 2026Medifast Announces Planned Leadership Transition

December 09, 2025OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing

November 13, 2025Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

November 03, 2025Medifast Announces Third Quarter 2025 Financial Results

November 03, 202510-Q Quarterly Report for 2025 Q3

October 27, 2025Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™

October 21, 2025Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025

September 15, 2025Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes

August 04, 2025Medifast Announces Second Quarter 2025 Financial Results

August 04, 202510-Q Quarterly Report for 2025 Q2

July 21, 2025Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025

April 28, 2025Medifast Announces First Quarter 2025 Financial Results

April 28, 202510-Q Quarterly Report for 2025 Q1

April 14, 2025Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025

February 18, 2025Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

February 18, 202510-K Annual Report for 2024 FY

February 04, 2025Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024

January 07, 2025Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off

December 05, 2024Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications

November 04, 2024Medifast Announces Third Quarter 2024 Financial Results

November 04, 202410-Q Quarterly Report for 2024 Q3

October 21, 2024Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

August 05, 2024Medifast Announces Second Quarter 2024 Financial Results

August 05, 202410-Q Quarterly Report for 2024 Q2

April 29, 202410-Q Quarterly Report for 2024 Q1

February 20, 202410-K Annual Report for 2023 FY

November 06, 202310-Q Quarterly Report for 2023 Q3

August 07, 202310-Q Quarterly Report for 2023 Q2

May 01, 202310-Q Quarterly Report for 2023 Q1

February 21, 202310-K Annual Report for 2022 FY

November 03, 202210-Q Quarterly Report for 2022 Q3

August 03, 202210-Q Quarterly Report for 2022 Q2

May 02, 202210-Q Quarterly Report for 2022 Q1

February 23, 202210-K Annual Report for 2021 FY

November 04, 202110-Q Quarterly Report for 2021 Q3
A. Company Overview
Medifast Inc., a prominent health and wellness entity, is renowned for its lifestyle solution, OPTAVIA®, which is habit-based and coach-guided. Established over 40 years ago by physicians, Medifast has evolved to become a leader in the U.S. weight management market. The company has recently expanded its offerings to include medically supported weight loss and sports nutrition, demonstrating a commitment to adapting to the dynamic needs of its customer base and the health industry.
Under current leadership, Medifast has transformed into a well-capitalized business with OPTAVIA evolving into a billion-dollar brand. The company boasts a robust network of over 41,100 active earning independent Coaches, influencing the lives of more than 3 million customers. Recent accolades include recognition from Financial Times as one of The Americas' Fastest Growing Companies in 2023 and inclusion in Forbes' list of America's Best Mid-Sized Companies in 2022.
Mission and Vision
Medifast’s mission, encapsulated in the slogan “Lifelong Transformation, One Healthy Habit at a Time®,” emphasizes the organization’s commitment to facilitating long-term health transformations for its community. By providing comprehensive health and nutritional solutions, the Company aims to address the evolving needs of its customer base effectively.
Business Model
The Medifast business model leverages a direct-selling approach, capitalizing on a network of independent OPTAVIA Coaches who provide personalized support to customers. This model is customer-centric, focusing on making healthy lifestyle changes rather than merely selling products. About 90% of OPTAVIA Coaches were customers before becoming Coaches themselves, enhancing the empathetic connection with prospective customers. Coaches utilize digital platforms, word of mouth, and social media to market products, ensuring a scalable approach to customer acquisition and support.
Medifast's offerings consist of:
- Independent Coaches: Trained individuals who provide personalized guidance and support to customers, reinforcing the habit-building process.
- OPTAVIA Community: A supportive network of like-minded individuals who encourage one another in their health journeys.
- Habits of Health® Transformational System: A proprietary system that provides structured steps toward adopting a sustainable healthy lifestyle.
- Products & Plans: A selection of clinically validated meal plans and scientifically developed products designed to meet users' nutritional needs.
Programs and Products
Medifast’s products include a diverse array of nutritious meal replacements known as Fuelings, which are designed to be nutrient-dense, portion-controlled, and easy to use. These Fuelings contain essential vitamins, minerals, and probiotics aimed at supporting digestive health. The product line has recently expanded to include OPTAVIA ACTIVE, a range of essential amino acid supplements and protein powders aimed at enhancing nutritional support for active individuals.
In collaboration with LifeMD, OPTAVIA customers gain access to board-certified clinicians and medication options, such as GLP-1s, which support comprehensive obesity treatment plans.
Competitors and Market Position
Medifast operates within a highly competitive weight loss and wellness industry, contending with various players, including traditional diet companies, direct sales organizations, and medically supervised solutions. Key competitors include USANA Health Sciences, WW International (formerly Weight Watchers), and Herbalife Nutrition.
Given the growing recognition of medical weight loss solutions—including GLP-1 medication—Medifast acknowledges both the challenges and opportunities this presents. Their holistic approach blends lifestyle modifications with medical resources, appealing to a broad spectrum of consumers seeking sustainable health solutions.
Recent Initiatives
In response to changing market dynamics, Medifast has begun new initiatives to grow its consumer base and enhance brand visibility since 2023. Significant investments have been directed towards marketing campaigns, upgrading digital interfaces, and expanding into the $30 billion sports nutrition market with the launch of the OPTAVIA ACTIVE product line.
The Company has also entered the realm of medically supported weight loss, integrating clinical guidance with OPTAVIA’s habit-forming approach, providing a comprehensive solution for individuals seeking long-term weight management.
Operational Structure
Medifast operates through several wholly-owned subsidiaries, including Jason Pharmaceuticals and OPTAVIA LLC. The Company maintains a manufacturing facility in Owings Mills, Maryland, which produces about 25% of its total unit sales. Remaining products are manufactured by external partners under stringent proprietary formulas and standards.
Financial Performance
With a solid financial foundation and no debt, Medifast is poised for strategic growth, focusing on capitalizing on its existing resources while redirecting capital from discontinued dividends to enhance marketing and technology initiatives aimed at customer acquisition.
Stock Infos
SectorConsumer Staples
IndustryHousehold and Personal Products
CEODaniel R. Chard
Dividends

Weight Loss Products & Services
Medifast specializes in weight management through its OPTAVIA® brand, offering a range of meal replacements, clinically validated meal plans, and support programs aimed at helping individuals achieve sustainable weight loss.

Nutritional Products
The company provides a variety of nutrient-dense meal replacements known as Fuelings, designed to support customers’ nutritional needs. This includes the expansion into protein powders and essential amino acid supplements under the OPTAVIA ACTIVE range.

Healthcare Services & Hospitals
Medifast not only provides dietary products but also integrates clinical guidance for medically supported weight loss, involving partnerships with board-certified clinicians to enhance its weight management solutions.

Customer Loyalty
The company has built a loyal customer base due to its effective weight loss programs and community support, which creates a high barrier for customers to switch to competing products.